跳至主要内容
临床试验/NCT05854589
NCT05854589尚未招募2 期

Effect of Topical Application of Hypertonic Saline on Melanoma on Its Sizes and Number.

Rafik Batroussy0 个研究点目标入组 20 人开始时间: 2023年8月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
20
主要终点
Melanoma size

研究概览

简要总结

This study evaluates the effectiveness of applying Hypertonic Saline solution directly on the Melanomas in reducing their sizes and/or number.

详细描述

Many previous studies have shown that Cancer cells are over-hydrated, and that Hyponatraemia exists in many cases of Cancer. The Cancer cell's viability depends on Angiogenesis and formation of blood vessels that carry water and nutrients to the rapidly-dividing Cancer cells. This study tests the hypothesis that reducing the water content of Melanoma could lead to increasing its tonicity and hence inhibiting its growth. This reduction of water content can be achieved using Osmotic Pressure differential via applying highly saline solution - made by Sodium Chloride crystals wet with water - directly on the Melanoma for a certain amount of time, thus leading to water withdrawal from Melanoma cells. While the surrounding healthy skin cells can sustain temporary dehydration, Melanoma cells could be negatively affected.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
5 Years 至 80 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Patients with clinically-confirmed Melanoma (any location and any stage) who have poorly responded to at least one cycle of conventional and standard therapy (Chemotherapy, Radiation or Drug therapy).
  • •Age 5 to 80 years old
  • •Life expectancy of at least 1 year
  • •Can understand and read English
  • •Lives in USA.
  • •Patient who do not meet the Inclusion Criteria but still wish to participate will be accepted as Observational participants, but their Melanoma measurements will be not be taken into account when analyzing the Study statistically.

排除标准

  • •Skin eczema and/or other skin conditions contraindicated to skin dehydration.
  • •Ulcers or open wounds close to Melanoma
  • •Any medical condition that might cause the patient to lose consciousness
  • •Participants who are not residents of USA.

研究组 & 干预措施

Active Group - Sodium Chloride Crystal Topical

Active Comparator

Each patient of the Active group will have their Melanoma covered by 2 drops of water, followed by applying Sodium Chloride granules to saturate the melanoma surface then add 2 more drops of water, then cover the NaCl-granules-covered Melanoma with a bandage. The bandage will stay in place for 12 hours daily and the procedure will be repeated daily for a total of 7 consecutive days, in addition to their standard treatments they receive from their health care providers, if any.

干预措施: Sodium Chloride Granules (Drug)

Control Group - Plain Water topical application

Placebo Comparator

Each patient of the Control group will have their Melanoma covered by 4 drops of water, then covered by a bandage. The bandage will stay in place for 12 hours daily and the procedure will be repeated daily for a total of 7 consecutive days, in addition to their standard treatments they receive from their health care providers, if any.

干预措施: Water (Other)

结局指标

主要结局

Melanoma size

时间窗: 6 month

Change in Melanoma's parameters such as length and width.

Melanoma number

时间窗: 6 month

Change in Melanoma number

次要结局

未报告次要终点

研究者

发起方
Rafik Batroussy
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Rafik Batroussy

Registered Pharmacist, Director

Batroussy, Rafik

相似试验